Preclinical Study Shows Targeted Drug Boosts CAR T-Cell Therapy in Pediatric Leukemias
A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib (brand name Xospata), a targeted cancer treatment, can strengthen chimeric antigen receptor (CAR)...